Related Experiment Videos
Experimental affective symptoms in panic disorder patients
Thea Overbeek1, Koen Schruers, Ine Docters van Leeuwen
1Academic Anxiety Center, Psychiatric Hospital Vijverdal, Maastricht, The Netherlands. thea.overbeek@pn.unimaas.nl
Summary
Carbon dioxide (CO2) challenges in panic disorder (PD) patients reveal that CO2 inhalation triggers anxiety, depression, and aggression. These effects are pronounced in PD patients with comorbid major depressive disorder (MDD).
Area of Science:
- Psychiatry
- Neuroscience
- Clinical Psychology
Background:
- Carbon dioxide (CO2) challenge tests are used to study panic disorder (PD).
- Previous research primarily focused on anxiety as the main outcome.
- A comprehensive assessment of affective symptoms is needed.
Purpose of the Study:
- To investigate the broader range of symptoms induced by CO2 challenge in PD patients.
- To compare symptom responses between PD patients with and without comorbid major depressive disorder (MDD).
Main Methods:
- Administered a 35% CO2 and 65% O2 gas mixture to 25 PD patients.
- Assessed symptoms of anxiety, depression, and aggression post-challenge.
- Subdivided patients into those with (n=9) and without (n=16) comorbid MDD.
Main Results:
- CO2 challenge increased ratings for anxiety, depression, and aggression in all PD patients.
- PD patients with comorbid MDD showed heightened responses in all affective symptoms compared to those without MDD.
- Specific panic symptoms were not significantly different between subgroups post-challenge.
Conclusions:
- CO2 inhalation is a potent inducer of anxiety, depressive, and aggressive symptoms in PD patients.
- Comorbid MDD exacerbates the affective response to CO2 challenge in PD.
- Findings highlight the complex interplay between PD, MDD, and physiological challenges.